初产妇接受椎管内麻醉后立即与延迟用力对自然分娩率的影响:一项随机临床试验
该实用随机临床试验纳入2414名≥37周妊娠、接受椎管内麻醉的初产妇,比较宫口开全后立即用力与延迟60分钟用力对自然分娩率的影响。结果显示两组自然分娩率无显著差异(85.9% vs 86.5%),立即用力组第二产程更短、绒毛膜羊膜炎和产后出血率更低,但新生儿发病率复合结局无显著差异。
要点
- 立即与延迟用力对自然分娩率无显著影响。
- 立即用力组第二产程平均缩短31.8分钟。
- 立即用力组绒毛膜羊膜炎和产后出血率更低。
核心结论
- 在接受椎管内麻醉的初产妇中,第二产程用力时机不影响自然分娩率。
研究设计与样本
- 实用随机临床试验,纳入2414名≥37周妊娠、接受椎管内麻醉的初产妇,来自美国6个医疗中心。
主要发现
- 自然分娩率立即组85.9% vs 延迟组86.5%,绝对差-0.6%(95%CI -3.4%至2.1%),无显著差异。
- 第二产程平均时长立即组102.4分钟 vs 延迟组134.2分钟,平均差-31.8分钟(95%CI -36.7至-26.9),P<.001。
- 活跃用力平均时长立即组83.7分钟 vs 延迟组74.5分钟,平均差9.2分钟(95%CI 5.8至12.6),P<.001。
- 绒毛膜羊膜炎发生率立即组6.7% vs 延迟组9.1%,组间差-2.5%(95%CI -4.6%至-0.3%),P=.005。
- 产后出血发生率立即组2.3% vs 延迟组4.0%,组间差-1.7%(95%CI -3.1%至-0.4%),P=.03。
临床怎么用
- 临床决策可结合其他母婴结局考虑第二产程用力时机,而非仅关注自然分娩率。
局限性
- 因无效性提前终止招募,实际样本2414例低于计划3184例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: It is unclear whether the timing of second stage pushing efforts affects spontaneous vaginal delivery rates and reduces morbidities. OBJECTIVE: To evaluate whether immediate or delayed pushing results in higher rates of spontaneous vaginal delivery and lower rates of maternal and neonatal morbidities. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic randomized clinical trial of nulliparous women at or beyond 37 weeks' gestation admitted for spontaneous or induced labor with neuraxial analgesia between May 2014 and December 2017 at 6 US medical centers. The interim analysis suggested futility for the primary outcome and recruitment was terminated with 2414 of 3184 planned participants. Follow-up ended January 4, 2018. INTERVENTIONS: Randomization occurred when participants reached complete cervical dilation. Immediate group participants (n = 1200) began pushing immediately. Delayed group participants (n = 1204) were instructed to wait 60 minutes. MAIN OUTCOMES AND MEASURES: The primary outcome was spontaneous vaginal delivery. Secondary outcomes included total duration of the second stage, duration of active pushing, operative vaginal delivery, cesarean delivery, postpartum hemorrhage, chorioamnionitis, endometritis, perineal lacerations (≥second degree), and a composite outcome of neonatal morbidity that included neonatal death and 9 other adverse outcomes. RESULTS: Among 2414 women randomized (mean age, 26.5 years), 2404 (99.6%) completed the trial. The rate of spontaneous vaginal delivery was 85.9% in the immediate group vs 86.5% in the delayed group, and was not significantly different (absolute difference, -0.6% [95% CI, -3.4% to 2.1%]; relative risk, 0.99 [95% CI, 0.96 to 1.03]). There was no significant difference in 5 of the 9 prespecified secondary outcomes reported, including the composite outcome of neonatal morbidity (7.3% for the immediate group vs 8.9% for the delayed group; between-group difference, -1.6% [95% CI, -3.8% to 0.5%]) and perineal lacerations (45.9% vs 46.4%, respectively; between-group difference, -0.4% [95% CI, -4.4% to 3.6%]). The immediate group had significantly shorter mean duration of the second stage compared with the delayed group (102.4 vs 134.2 minutes, respectively; mean difference, -31.8 minutes [95% CI, -36.7 to -26.9], P < .001), despite a significantly longer mean duration of active pushing (83.7 vs 74.5 minutes; mean difference, 9.2 minutes [95% CI, 5.8 to 12.6], P < .001), lower rates of chorioamnionitis (6.7% vs 9.1%; between-group difference, -2.5% [95% CI, -4.6% to -0.3%], P = .005), and fewer postpartum hemorrhages (2.3% vs 4.0%; between-group difference, -1.7% [95% CI, -3.1% to -0.4%], P = .03). CONCLUSIONS AND RELEVANCE: Among nulliparous women receiving neuraxial anesthesia, the timing of second stage pushing efforts did not affect the rate of spontaneous vaginal delivery. These findings may help inform decisions about the preferred timing of second stage pushing efforts, when considered with other maternal and neonatal outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02137200.
引用
- Cahill AG, Srinivas SK, Tita ATN, et al. Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial Analgesia: A Randomized Clinical Trial. JAMA. 2018. PMID: 30304425. doi:10.1001/jama.2018.13986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。